Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA4 | P22748 | 2/20 | 0.43 |
| ▸ | CYP4F2 | P78329 | 2/20 | 0.43 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.43 |
| ▸ | CES2 | O00748 | 1/20 | 0.41 |
| ▸ | CES1 | P23141 | 1/20 | 0.41 |
| ▸ | PREP | P48147 | 3/20 | 0.41 |
| ▸ | CELA1 | Q9UNI1 | 2/20 | 0.41 |
| ▸ | KDR | P35968 | 1/20 | 0.41 |
| ▸ | BACE1 | P56817 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 3/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.39 |
| ▸ | TP53 | P04637 | 1/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.38 |
| ▸ | TOP1 | P11387 | 1/20 | 0.38 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22701893 | 0.88 | CYP4F2 (0.37) | CA1CA2CA4CYP4F2CYP4A11 | |
| SCHEMBL12342059 | 0.87 | KDM4E (0.42) | CYP4F2CYP4A11CES2CES1PREP | |
| SCHEMBL24436821 | 0.86 | PREP (0.41) | CA1CA2CA4CYP4F2CYP4A11 | |
| SCHEMBL9839630 | 0.84 | KDM4E (0.46) | CYP4F2CYP4A11CES2CES1PREP | |
| SCHEMBL27437747 | 0.84 | POLB (0.41) | CYP4F2CYP4A11CES2CES1PREP | |
| SCHEMBL18697369 | 0.83 | CA1 (0.44) | CA1CA2CA4CYP4F2CYP4A11 | |
| SCHEMBL2153565 | 0.83 | CA1 (0.44) | CA1CA2CA4CYP4F2CYP4A11 | |
| SCHEMBL28510483 | 0.82 | MTNR1A (0.34) | CA1CA2CA4CYP4F2CYP4A11 | |
| SCHEMBL2003057 | 0.82 | CES2 (0.45) | CYP4F2CYP4A11CES2CES1PREP | |
| SCHEMBL29000115 | 0.82 | PREP (0.40) | CA2CYP4F2CYP4A11PREPCELA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106089592-B | A kind of double blades wind power generating set with vertical shaft and its working method | 徐州工程学院 | 2018-08-03 | — | — | CN | claimed |
| CN-106089592-A | A kind of double blade wind power generating set with vertical shaft and method of work thereof | 徐州工程学院 | 2016-11-09 | — | — | CN | claimed |
| US-8952083-B2 | Fluorocopolymer composition and its production process | ASAHI GLASS COMPANY, LIMITED (JP) | 2015-02-10 | — | — | US | claimed |
| WO-2024121632-A1 | USE OF ANTI-CD117 ANTIBODY DRUG CONJUGATE (ADC) | CRISPR THERAPEUTICS AG (CH) | 2024-06-13 | — | — | WO | disclosed |
| WO-2024062319-A1 | POLYMERS WITH DUAL THERAPEUTIC AGENTS | Sony Group Corporation (JP) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024044554-A1 | VHH ANTIBODY CONJUGATES WITH HETEROARYL CHELATORS | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044549-A1 | VHH ANTIBODY CONJUGATES | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| WO-2024044552-A1 | VHH ANTIBODY DOTA CONJUGATES | Abdera Therapeutics Inc. (US) | 2024-02-29 | — | — | WO | disclosed |
| EP-3737418-B1 | POLYMERS WITH RIGID SPACING GROUPS COMPRISING BIOLOGICALLY ACTIVE COMPOUNDS | SONY GROUP CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3294811-B1 | ULTRA BRIGHT DIMERIC OR POLYMERIC DYES | SONY GROUP CORP (JP) | 2024-02-28 | — | — | EP | disclosed |
| EP-3455299-B1 | COMPOSITIONS COMPRISING A POLYMERIC DYE AND A CYCLODEXTRIN AND USES THEREOF | SONY GROUP CORP (JP) | 2024-01-17 | — | — | EP | disclosed |
| US-20090162290-A1 | METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF | THERAPHARM GMBH | 2009-06-25 | — | — | US | disclosed |
| US-20090162290-A1 | METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF | THERAPHARM GMBH | 2009-06-25 | — | — | US | disclosed |
| WO-2009075778-A2 | NONPEPTIDIC INHIBITORS OF CRUZAIN | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2009-06-18 | — | — | WO | disclosed |
| WO-2008056897-A1 | CASPASE INHIBITORS BASED ON PYRIDAZINONE SCAFFOLD | LG LIFE SCIENCES LTD. (KR) | 2008-05-15 | — | — | WO | disclosed |
| US-20070071673-A1 | Trifunctional reagent for conjugation to a biomolecule | MITRA MEDICAL TECHNOLOGY AB (SE) | 2007-03-29 | — | — | US | disclosed |
| US-20070071673-A1 | Trifunctional reagent for conjugation to a biomolecule | MITRA MEDICAL TECHNOLOGY AB (SE) | 2007-03-29 | — | — | US | disclosed |
| WO-2007028639-A1 | METHOD FOR THE SYNTHESIS OF PENTAPENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIO-CONJUGATES PREPARATION BY A COVALENT BINDING OF THEREOF | THERAPHARM GMBH (CH) | 2007-03-15 | — | — | WO | disclosed |
| WO-2006033551-A1 | CASPASE INHIBITORS CONTAINING DICARBONYLAMINO-ISOXAZOLINE | LG LIFE SCIENCES LTD. (KR) | 2006-03-30 | — | — | WO | disclosed |
| WO-2005035497-A1 | CASPASE INHIBITOR COMPRISING 2-ALKYL-4-OXOBUTANOYL GROUP AND PHARMACEUTICAL COMPOSITION THEREOF | LG LIFE SCIENCES LTD. (KR) | 2005-04-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070071673-A1 | Trifunctional reagent for conjugation to a biomolecule | UACA, TNFSF11, CD40 | CA1 2939/4885CA2 3860/4885CA4 2754/4885 |
| US-20090162290-A1 | METHOD FOR THE SYNTHESIS OF PENTA-PENDANT ENANTIOMER-PURE CHELATORS AND PROCESS FOR THERAPEUTICALLY ACTIVE BIOCONJUGATES PREPARATION BY A COVALENT BINDING THEREOF | C5, C3AR1, SPR | CA1 291/4885CA2 1448/4885CA4 872/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.